Clinical Trials Browser

OTHER × Malignant Solid Tumors × asciminib × Clear all

NCT06629584 2026-02-17

Phase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid Leukemia

Phase 2 Recruiting

Other solid neoplasm

Malignant Solid Tumors